Tumor growth was inhibited by treatment with tamoxifen plus GDC-0032, but not by tamoxifen alone (Figure 6D), and this combined treatment resulted in decreased FOXM1 and LDHA expression (Figure 6E). Here, FOXM1 is linked to neoplasm.